Does NELVUTAMIG Cause Immune-mediated thyroiditis? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Immune-mediated thyroiditis have been filed in association with NELVUTAMIG. This represents 2.2% of all adverse event reports for NELVUTAMIG.
6
Reports of Immune-mediated thyroiditis with NELVUTAMIG
2.2%
of all NELVUTAMIG reports
1
Deaths
5
Hospitalizations
How Dangerous Is Immune-mediated thyroiditis From NELVUTAMIG?
Of the 6 reports, 1 (16.7%) resulted in death, 5 (83.3%) required hospitalization, and 2 (33.3%) were considered life-threatening.
Is Immune-mediated thyroiditis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NELVUTAMIG. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does NELVUTAMIG Cause?
Off label use (29)
Immune-mediated hepatitis (18)
Hypothyroidism (17)
Immune-mediated enterocolitis (16)
Malignant neoplasm progression (16)
Colitis (15)
Drug ineffective (14)
Immune-mediated hepatic disorder (14)
Fatigue (13)
Immune-mediated myocarditis (11)
What Other Drugs Cause Immune-mediated thyroiditis?
PEMBROLIZUMAB (189)
NIVOLUMAB (156)
IPILIMUMAB (109)
CARBOPLATIN (50)
PACLITAXEL (34)
LENVATINIB (29)
CYCLOPHOSPHAMIDE (13)
PEMETREXED (11)
ACETAMINOPHEN (10)
ASPIRIN (10)
Which NELVUTAMIG Alternatives Have Lower Immune-mediated thyroiditis Risk?
NELVUTAMIG vs NEMOLIZUMAB
NELVUTAMIG vs NEMOLIZUMAB-ILTO
NELVUTAMIG vs NEOMYCIN
NELVUTAMIG vs NEORAL
NELVUTAMIG vs NEOSTIGMINE